C1 esterase inhibitor recombinant Intravenous and Physostigmine Ophthalmic
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Physostigmine Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: physostigmine ophthalmic
Brand name:
Synonyms: Physostigmine (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Physostigmine Salicylate
- C1 esterase inhibitor recombinant Intravenous-Phytonadione
- C1 esterase inhibitor recombinant Intravenous-Phytonadione Injection
- C1 esterase inhibitor recombinant Intravenous-Phytonadione oral/injection
- C1 esterase inhibitor recombinant Intravenous-Phytonadione Orally Disintegrating Tablets
- C1 esterase inhibitor recombinant Intravenous-Phytonadione Tablets
- Physostigmine Ophthalmic-C1 esterase inhibitor, human Intravenous
- Physostigmine Ophthalmic-C1 Inhibitor (Human)
- Physostigmine Ophthalmic-C1 Inhibitor (Human) (Berinert)
- Physostigmine Ophthalmic-C1 Inhibitor (Human) (Cinryze)
- Physostigmine Ophthalmic-C1 Inhibitor (Human) (Haegarda)
- Physostigmine Ophthalmic-C1 Inhibitor (Recombinant)